Therapeutic Peptides
Research-grade compounds for tissue repair, regeneration, and recovery biology.
Therapeutic peptides represent one of the most extensively studied classes of synthetic compounds in modern pre-clinical biology. From gastric cytoprotection and tendon repair to neurological recovery and immune modulation, these compounds have generated substantial published evidence across multiple tissue types and injury models.
Research-grade therapeutic peptides like BPC-157 and TB-500 are used by academic institutions, pharmaceutical research teams, and pre-clinical laboratories studying the mechanisms of angiogenesis, cellular migration, growth factor signaling, and tissue homeostasis. With over 100 peer-reviewed publications on BPC-157 alone, therapeutic peptides occupy a central place in contemporary regenerative medicine research.
Research Applications & Benefits
Angiogenesis & Vascular Repair
Compounds like BPC-157 upregulate VEGF to restore blood supply to hypovascular injured tissue — tendon, ligament, and nerve — accelerating the delivery of repair cells and growth factors.
Gastrointestinal Cytoprotection
Therapeutic peptides have the most robust published evidence in GI models — gastric ulcer, colitis, and intestinal anastomosis — with measurable effects documented within 24–72 hours of administration.
Musculoskeletal & Tendon Research
Multiple studies in Achilles tendon transection and MCL models document statistically significant improvements in tensile strength, collagen organization, and fibril alignment at 14–28 days.
Immune & Systemic Modulation
Thymosin Alpha-1 and related compounds have established roles in immune system research, with documented effects on T-cell activation, NK cell function, and cytokine regulation in pre-clinical and clinical settings.
Common Research Use Cases
Therapeutic Peptides — Product Catalog
Frequently Asked Questions
Common questions from researchers working with therapeutic peptides.